Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-02-01

FDA Approved: NIACIN — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved Aurobindo Pharma Limited's original ANDA for NIACIN, a generic niacin product intended to treat dyslipidemia and related lipid disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Niacin (nicotinic acid)

Snippet

ORIG AP for NIACIN (NIACIN)